The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

BackgroundCirculating tumor DNA (ctDNA) is an emerging biomarker in malignant melanoma(MM), and high levels of ctDNA may reflect a higher tumor load. However, its prognostic value for MM receiving immune checkpoint inhibitors(ICI) remains controversial. This meta-analysis aimed to elucidate the prog...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lei Liu, Shufu Hou, Aiping Zhu, Bing Yan, Linchuan Li, Dandan Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	circulating tumor DNA immune checkpoint inhibitors malignant melanoma overall survival progression-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520441/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic significance of circulating tumor DNA in urothelial carcinoma patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
by: Qingping Ma, et al.
Published: (2025-04-01)

Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis
by: Xiumin Zhao, et al.
Published: (2025-04-01)

Comparative effectiveness among BRAF plus MEK inhibitors for patients with BRAF V600-mutant melanoma☆
by: G.K. In, et al.
Published: (2024-12-01)

Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis
by: Konstantinos Lallas, et al.
Published: (2025-01-01)

Predicting overall survival benefit in previously untreated, unresectable or metastatic melanoma from improvement in progression-free survival: a correlation meta-analysis
by: Peter Mohr, et al.
Published: (2025-06-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Establishment and Validation of Prognostic Nomograms for Nonmetastatic Melanoma of the Limbs—A SEER-Based Study
by: Yutong Shi, et al.
Published: (2024-01-01)

Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
by: Yan Ou, et al.
Published: (2024-10-01)

Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
by: Katarzyna Borys, et al.
Published: (2025-05-01)

Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
by: Charlotte Maulat, et al.
Published: (2024-11-01)

Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma
by: Yi Teng, et al.
Published: (2025-08-01)

The global progress and quality assessment of research on the association between circulating tumor DNA and clinical prognosis: a systematic review
by: Meng Zhang, et al.
Published: (2025-04-01)

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Zhe Wang, et al.
Published: (2025-05-01)

Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma
by: Xiaohan Wang, et al.
Published: (2025-02-01)

Optimal early endpoint for second-line or subsequent immune checkpoint inhibitors in previously treated advanced solid cancers: a systematic review
by: Jingqiu Li, et al.
Published: (2025-02-01)

Extended Survival and Prognostic Factors in Endometrial Cancer: A Multivariate Cox Regression Analysis
by: Irene Valencia Téllez, et al.
Published: (2024-12-01)

Long-term survival of uveal melanoma patients with respect to clinical, hemodynamic and morphological characteristics of the tumor
by: S. V. Saakyan, et al.
Published: (2022-07-01)

Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis
by: Lin Zhu, et al.
Published: (2024-12-01)

Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma
by: S. K. Zyryanov, et al.
Published: (2024-02-01)

COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors
by: Augustin Boudoussier, et al.
Published: (2025-05-01)

Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis
by: Diana Zhang, et al.
Published: (2025-03-01)

Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach
by: A. G. Tolkushin, et al.
Published: (2019-01-01)

Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review
by: Elyar Mahboubi, et al.
Published: (2025-05-01)

The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
by: Made Agus Mahendra Inggas, et al.
Published: (2025-03-01)

Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study
by: Narendranath Epperla, et al.
Published: (2025-05-01)

A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma
by: Xiang Guo, et al.
Published: (2025-04-01)

Nomograms predicting cancer-specific survival and overall survival of advanced salivary gland malignancy patients: a study based on the SEER database
by: Congzhi Ma, et al.
Published: (2025-05-01)

The role of Lobectomy in Glioblastoma management: A Retrospective series
by: Christina K. Arvaniti, et al.
Published: (2025-01-01)

Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Bo-Wen Zhuang, et al.
Published: (2022-12-01)

Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
by: Valeria V. Nazarova, et al.
Published: (2025-05-01)

CHARACTERISTICS AND SURVIVAL OF BRAIN METASTASIS FROM TWO RADIORESISTANT TUMORS, MALIGNANT MELANOMA AND RENAL CELL CARCINOMA: A SINGLE RADIOTHERAPY CENTER STUDY
by: Zümrüt Bahat, et al.
Published: (2023-01-01)

Construction of a clinical prediction model for overall survival and cancer-specific survival in malignant phyllode tumor of the breast based on the SEER database
by: Chenggeng Pan, et al.
Published: (2025-07-01)

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
by: Zhiyong Wan, et al.
Published: (2025-01-01)

Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer
by: B. Miron, et al.
Published: (2024-03-01)

TMPRSS4 as a prognostic biomarker after gastric cancer surgery in a multicenter retrospective study
by: Hirofumi Tazawa, et al.
Published: (2025-03-01)

Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial
by: Chang Yin, et al.
Published: (2025-07-01)

Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility
by: Santosh Kumar Swain, et al.

Association of Log Odds of Positive Lymph Nodes with Overall Survival in Patients with Primary Malignant Anorectal Melanoma: A Population-Based Study
by: Shaofeng Liu, et al.
Published: (2025-12-01)

Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy
by: Aya F. Ozaki, et al.
Published: (2025-03-01)

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
by: Nargiz Majidova, et al.
Published: (2025-01-01)